AzTrials
AzTrials

Attention-deficit/Hyperactivity Disorder.NCT02184598

Randomized Controlled Trial With Use of Cognitive Training in Children and Adolescents With ADHD

A study testing Cognitive training in people with Attention-deficit/Hyperactivity Disorder., run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Purpose: This project assess the effectiveness of a cognitive training as an add-on intervention to drug treatment in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) compared to a placebo training. Read more about this study

Who is it for?
Ages 6 to 13 years
What is being tested?
Cognitive training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
60 participants
Where
1 siteBrazil
Study dates
Jul 2014to Dec 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 to 13 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Male or female, age 6 to 13 years, ADHD diagnosis (DSM-V)
  • Medicated and stabilized individuals with psychostimulant with residual symptoms of inattention - mean scores of parents and teachers > or = 1)

Who cannot join

  • Presence of other comorbid mental disorder that is clinically significant and requiring treatment at the time of entry in the protocol.
  • intelligence quotient (IQ) < 80

Trial locations and contacts

1 site in 1 country.

Brazil1 site
  • Hospital de Clínicas de Porto Alegre

    Porto Alegre, Rio Grande do Sul, 90035-003

Other trials in Brazil

About this study

Official title: Randomized Controlled Trial With Use of Cognitive Training in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

Purpose: This project assess the effectiveness of a cognitive training as an add-on intervention to drug treatment in children and adolescents diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) compared to a placebo training. The cognitive training consists of 6 computerized games that are based on principles of neuroplastic change.

ADHD: current treatment - International clinical guidelines indicate that pharmacological interventions in particular stimulants are the first-line treatment for ADHD. However, about 30% of children affected by the disorder do not respond to medication alone, exhibit partial response or can not tolerate the adverse effects. In addition there is a group of parents who do not accept the use of medication for the treatment of ADHD in their children. In recent years cognitive training has received considerable attention as a treatment to ADHD. The evidence base for cognitive training programs are still forming with few randomized placebo-controlled studies. However, this approach seems to be effective either as a treatment for ADHD - and others cognitive disorders in childhood - or as a tool to enhance cognitive ability and school performance in children and adults. No previous study has evaluated this cognitive intervention in a clinical trial with placebo-controlled intervention and as an adjunctive treatment to medication. Additionally, the investigators will assess brain changes associated with this intervention using neuroimaging (fMRI).

Read the detailed description

Material and Methods Trial design Randomized clinical trial with placebo control. This study will compare the cognitive training program versus the placebo condition to assess the reduction on residual symptoms, the improvement in the neurocognitive function and brain activation changes in children and adolescents with ADHD receiving stimulants. Sixty subjects, six to thirteen years-old with ADHD confirmed by the Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS) will be randomly assigned to 12 weeks of cognitive or placebo training.

Participants To be included in the study children and adolescent need to meet the following criteria (a) age between 6-13 years, (b) a diagnosis of ADHD classified according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders (5th edition), (c) medicated and stabilized with psychostimulants but partially restored - inattention SNAP score (mean scores of parents and teachers > or = 1), (d) a full scale intelligence quotient (IQ) of at least 80, (e) access to a computer with windows vista 7 and speakers, and access to internet. Participants will be excluded in case (a) another comorbid psychiatry diagnosis clinically significant and requiring treatment at the time of enter in the study protocol.

Sample Size Calculation There was no previous study that used the design proposed in this investigation. Considering a reduction 20% higher of the SNAP-IV scores in the active group intervention (stimulants + cognitive training), sample size in both groups of 27 participants and standard-deviation in the magnitude of half of the medium score in each group (moderate variability), the study will be able to detect a moderate effect size (ES = 0,4). Calculating a sample loss of 10% each group, we define a sample size per group of 30 individuals.

Cognitive intervention protocol:

A portuguese version of the new Cognitive Computerized Training was created with the partnership of Yale University research team.

The cognitive training program is composed by computerized exercises with six different games divided in multiples levels and sublevels with increasing difficulty. During the games, several neuropsychological domains are required from the participant such working memory, sustained attention, response inhibition and others. In each session the participant will play 6 games divided in 5 minutes blocks. The aim of these games is to engage and activate targeted neurocognitive systems This protocol will be run in schools. It will be consisted of 4 times/week sessions (3 times at school and 1 time at home) for 12 weeks with 30 min of duration.

The placebo cognitive training (control group) will contain the same exposure time of the active group but without any element regarding to the cognitive training.

Pharmacological protocol All subjects must be receiving pharmacological treatment for ADHD with a stable dose of stimulants for at least 1 month in doses not inferior of 0.3mg/kg/per day of methylphenidate or 30mg/per day of lisdexamphetamine. Any increase in doses during the protocol will be permitted.

Neuropsychological protocol An assessment before the beginning of the intervention and pos-treatment will be done by a trained neuropsychologist using three tests of a NIH toolbox (C8Kids platform): Flanker Test, Go/NoGo Test and List Sorting Test of Working Memory and a neuropsychological battery created by our team using six tests: CPT II (Conner´s Continuous Performance Test II), Digit Span, Spatial Span, Reaction Time Task, Trail Making Test and Picture Concepts.

Neuroimaging protocol A subgroup of 10 participants from each group will be drawn to a functional resonance exam (MRIf) before and immediately after the cognitive or placebo training. During the exam they will do a neuropsychological tests ( Go/NoGo; N-Back - working memory - and SAT - sustained attention test).

Statistical methods Statistical analyses will be performed with Statistical Package for the Social Sciences (SPSS) 12.0. The univariate analyses will be performed with the t student test / Mann-Whitney to continuous variables or Chi-Square test (X²) / Fischer test to categorical variables. The variables that present relationship with the outcomes will be maintained in multivariate models. The effective of the intervention over time will be assess through analyses of mixed models.

Being tested
Cognitive training, Placebo cognitive training
Keywords
ADHD, Cognitive training, fMRI, Cognitive function
Medical subject headings
Attention Deficit Disorder with Hyperactivity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Cognitive trainingBehavioural

    12 weeks of cognitive training; 4 sessions/week; duration 30 min

  • Placebo cognitive trainingBehavioural

    In the control group, we will use a placebo training that will consist of the same exposure time of the active training but not related to any element of cognitive training. To this end, we will set up an online platform with quiz and educational videos - being the most related to school content - without any component of executive function or working memory.

Study groups in NCT02184598
Study groupRoleWhat they receive
Placebo cognitive trainingPlacebo comparatorIn the control group, we will use a placebo training that will consist of the same exposure time of the active training but not related to any element of cognitive training. To this end, we will set up an online platform with quiz and educational videos - being the most related to school content - without any component of executive function or working memory.
Receives: Behavioral: Placebo cognitive training
Cognitive trainingExperimentalCognitive training with 6 different games each of which gets progressively more difficult as children obtain proficiency.
Receives: Behavioral: Cognitive training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in ADHD symptomatology

    Measured by the SNAP scale filled by parents and teachers.

    Measured: Baseline; 12 weeks.

Secondary outcomes (3)
  1. Change in neuropsychological function.

    Working memory, inhibitory control, executive function and delay aversion.

    Measured: Baseline; 12 weeks.

  2. Change in activation of front-striatal and parietal brain areas in functional magnetic resonance imaging (fMRI) during a neuropsychological test.

    Measured: Baseline; 12 weeks.

  3. Change in the hours and characteristic of internet use

    measured by an appropriate scale (IAT - Internet Addiction Test)

    Measured: Baseline; 12 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Jul 2014 (estimated)
  2. Study startJul 2014
  3. Primary completionJul 2016 (estimated)
  4. Study completionDec 2016 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02184598
Sponsor's protocol ID
125002
Status last verified
Dec 2015
First submitted
4 Apr 2014
Last updated
22 Dec 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Cognitive training in people with Attention-deficit/Hyperactivity Disorder., run by Hospital de Clinicas de Porto Alegre at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Dec 2015. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in ADHD symptomatology (time frame: Baseline; 12 weeks.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Dec 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in